← Leaderboards
Duygu Tosun-Turgut
University Of California, San Francisco
$5,960,415
Attributed
$12,850,338
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,850,338 · 6
By mechanism
R01$11,125,366 · 4
U19$1,724,972 · 2
Top collaborators
- Robert Scott Mackin6 shared
- Michael G Agadjanyan1 shared
- James E Galvin1 shared
- Katherine P Rankin1 shared
- Lon S Schneider1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Margaret E Feeney$17,736,942
- Orion D Weiner$14,865,661
- Zvavahera Mike Chirenje$118,149,266
- Robert Scott Mackin$13,397,417
- Nisha Bansal$11,641,413
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposParticipantS DiseaseMagnetic Resonance ImagingDesignBiological MarkersNeuroimagingElderlyBrainEnrollmentEvaluationCharacteristicsMultidisciplinaryCognitiveCerebrovascular DisordersProtocols DocumentationAtrophicProgramsClinical DataSeveritiesNerve DegenerationPositron-Emission TomographyImageAging
Grant awards (11)
FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.$5,308,961
R01 · FY2025 · AG
Clarifying the association of depressive symptoms with cortico-limbic tau, cerebral blood flow, neurodegeneration, and longitudinal cognitive decline in individuals with mild cognitive impairment$1,711,908
R01 · FY2025 · AG
Autopsy-informed integrated clinical and imaging models for prediction of non-AD co-pathologies in AD$791,086
R01 · FY2025 · AG · contact PI
Project 1$503,275
U19 · FY2025 · AG · contact PI
Project 1$581,563
U19 · FY2023 · AG · contact PI
Project 1$640,134
U19 · FY2022 · AG · contact PI
Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression$658,123
R01 · FY2019 · MH
Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression$651,368
R01 · FY2018 · MH
Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression$648,314
R01 · FY2017 · MH
Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression$662,758
R01 · FY2016 · MH
Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression$692,848
R01 · FY2015 · MH